Short-Course Apalutamide to Reduce Active Surveillance Attrition in Prostate Cancer Editorialists question whether any intervention violates principles of surveillance Jan 17, 2023
MRI-Guided Focused Ultrasound Eases Pain From Bone Metastases More responses with ultrasound, but quality-of-life scores lower vs EBRT in nonrandomized trial Jan 11, 2023
MRI-Targeted Biopsy for Prostate Cancer Reduces Risk of Overdiagnosis Though at the cost of delayed diagnosis of some clinically significant cancers Dec 07, 2022
Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients? Barriers exist in identifying risk, but strategies are available Dec 06, 2022
Metastasis-Directed Therapy May Delay ADT in Advanced Prostate Cancer Surgery or radiation delayed initiation of systemic therapy by 18 months Nov 29, 2022
Primary Care Visits Prior to Cancer Diagnosis Tied to Lower Mortality Most benefit with annual visits, but even some use linked to better outcomes Nov 16, 2022
Could a Plant-Based Diet Benefit Men's Health Below the Belt? Analysis suggests protective nature of veggie-heavy diet in prostate cancer and more Oct 30, 2022
Good, and Safe, Results Tied to Oral Testosterone in Men With Deficiency Meta-analysis should spur more research on newer formulations, researcher says Oct 30, 2022
Metastasis-Directed Therapy for Prostate Cancer Increases PFS, Time off Hormones Radiotherapy led to "dramatic" slowing of progression, increased time with normal testosterone Oct 27, 2022
Sexual Health Not Part of Discussion for Women Undergoing Brachytherapy Much less likely than men to be queried about sexual function when receiving treatment Oct 25, 2022
Shorter Course of Radiation Therapy Proves Mettle in High-Risk Prostate Cancer Hypofractionation matches standard RT for survival and toxicity in a third less time Oct 25, 2022
Low Rates of PSA Screening Linked to Increase in Metastatic Prostate Cancer Will USPSTF's 2018 guidelines reverse this trend? Oct 25, 2022
High-Dose-Rate Brachytherapy Boost in Prostate Cancer Improves QOL Patients report better urinary and bowel function outcomes Oct 24, 2022
Clinical Decision Tool Cuts Inappropriate BMA Therapy in Prostate Cancer Study at VA center shows better disease-related bone healthcare Sep 18, 2022
Long-Term ADT With Radiation Helps Prevent Post-Prostatectomy Metastases However, no benefit seen with short-term hormone therapy versus radiotherapy alone Sep 13, 2022
Rezvilutamide Bests Bicalutamide in Metastatic Prostate Cancer Combined with ADT, the androgen-receptor inhibitor significantly improved OS, radiographic PFS Sep 07, 2022
A Light at the End of the Tunnel for Low-Risk Prostate Cancer? The MUSIC model might improve quality of life and prevent overtreatment Sep 02, 2022
How Realistic Is Radical Prostatectomy Without Prior Biopsy? German case series suggests it may be feasible Jul 12, 2022
MRI-Guided HIFU Effective in Intermediate-Risk Prostate Cancer QOL outcomes compared favorably with radical prostatectomy and radiotherapy, researchers said Jun 17, 2022
Xtandi During AS Reduced Progression Risk in Early Prostate Cancer Risk of disease progression cut by 46% versus those on active surveillance alone Jun 16, 2022
P53 Antagonist Shows Early Activity in Advanced Liposarcoma ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
She Found Out She Had Prostate Cancer Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
Just How Effective Is PSA Screening? Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
Mental Health Issues Common, Often Overlooked in Prostate Cancer More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
Urologists Are Helping Combat the Opioid Epidemic, Studies Suggest Three reports show success in reducing opioid prescribing May 16, 2022
End of the Line for a Failed Prostate Cancer Drug Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
Another Link Between Prostate Cancer Hormone Tx and Impaired Cognition Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
Stop Calling It Cancer; AI Gets a Win in Bladder Cancer; Lack of Price Transparency News, features, and commentary about cancer-related issues Apr 22, 2022
Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dx Consistently low PSA levels failed to signal metastasis Apr 18, 2022
Genetic Score Shows Promise for Honing PSA Precision Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rights Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
Artificial Sweeteners Not So Sweet When It Comes to Cancer Risk Consumption of certain sugar alternatives linked to a 13% higher risk of developing cancer Mar 24, 2022
Cancer May Heighten Odds of Guillain-Barre Syndrome Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancer Docetaxel-enzalutamide regimen may offer another option for men who progressed on AR inhibitor Feb 18, 2022
Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPC In one case, rPFS benefit was seen regardless of HRR mutational status Feb 18, 2022
Darolutamide Improves OS in Metastatic Prostate Cancer The AR inhibitor plus standard therapy led to a 32% reduced risk of death versus placebo Feb 17, 2022
Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancer In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo Feb 10, 2022
We've Never Really Understood the Prostate Wolinsky reviews Ericka Johnson's new book, A Cultural Biography of the Prostate Jan 19, 2022
In Early Prostate Cancer, Black Men Do Better With Radiotherapy Than White Men "Unexpected" finding holds even though Black men are more likely to have high-risk features Dec 29, 2021
NCCN Reverses on Guideline Change for Surveillance in Prostate Cancer Active surveillance again preferred choice for "most" men with low-risk disease Dec 01, 2021
